-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
-
Cosmetic Ingredient
- Water Treatment Chemical
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
[Pharmaceutical Network Conference Forum] In June, the fragrance of lotus flowers, on June 10-11, the "2021 Drug Quality Control and Inspection Technology Forum" hosted by the Pharmaceutical Analysis Professional Committee of Zhejiang Pharmaceutical Association and hosted by Hangzhou Qiyi Technology Co.
, Ltd.
Hangzhou kicked off, and many experts and teachers from the pharmaceutical industry gathered together
.
During the two days, more than 300 industry colleagues from pharmaceutical companies QC, drug regulatory agencies, drug inspection institutes, and pharmaceutical company managers participated in the conference! During the two days, big names gathered, and everyone benefited a lot.
The content of the report was splendid and presented an academic feast.
Speech by the Secretary of the Professional Committee of Pharmaceutical Analysis of Zhejiang Pharmaceutical Association Li Yang, Deputy Director of the Professional Committee of Pharmaceutical Analysis of Zhejiang Pharmaceutical Association, Vice President Li of Zhejiang Provincial Institute of Food and Drug Inspection delivered an enthusiastic opening speech, which opened the At the prelude of the conference, President Li said: With the continuous improvement of the quality of life, people are paying more and more attention to health, and the demand for food and drug safety has been incorporated into an important indicator for measuring a well-off society
.
Investing in health has become a consumption fad and a hot pursuit
.
Therefore, drug quality control is a crucial step
.
This year is the year of the implementation of the 2020 edition of the "Chinese Pharmacopoeia".
The "Chinese Pharmacopoeia" is the standard for drug safety, and in a strict sense, it is also a firewall for drug safety
.
The advent of the "Chinese Pharmacopoeia" has greatly improved the standards of medicines.
It is a medicine code formulated by the state to ensure the controllable quality of medicines and the safety and effectiveness of the people's medicines.
It must be strictly followed in the development, production, operation, use and management of medicines.
The legal basis is the core of the national drug standard system and an important part of international exchanges and cooperation
.
It has promoted the overall improvement of China's drug testing and testing skills, and also strengthened drug testing and control
.
Dean Li spoke highly of and affirmed the preparation and organization of this conference
.
Finally, I wish this forum a complete success! In just two days, speakers from the Pharmacopoeia Committee, regulatory authorities, and enterprises shared nearly 25 keynote reports on the interpretation of the 2020 edition of the Chinese Pharmacopoeia, cutting-edge technologies and challenges in modern pharmaceutical analysis, injections, and pharmaceutical raw materials.
, Chemical organic impurities and elemental impurities research, related substance research and residual solvent determination, Chinese medicine standard research, Chinese herbal medicine and Chinese medicine decoction pieces, microbial quality control research and case analysis, laboratory biosafety management, drug microbiology laboratory management and common problems and other issues to discuss, analyze and preach laboratory management experience, drug analysis and detection and microbial control and other problems
.
General Assembly Yu Lushan Deputy Director of the Pharmaceutical Analysis Professional Committee of Zhejiang Pharmaceutical Association, Deputy Director of the Institute of Drug Metabolism and Drug Analysis, School of Pharmacy, Zhejiang University "Frontier Technologies and Challenges in Modern Pharmaceutical Analysis" Wang Jian Member of the State Pharmacopoeia Committee, Zhejiang Provincial Food and Drug Inspection Research Institute "two-dimensional liquid chromatography-mass spectrometry technology and its application in the analysis of high-risk impurities in antibiotics" Li Yu Zhejiang Institute of Food and Drug Inspection "Compatibility Research and Case Analysis of Polymorphic Drug Raw Materials and Excipients" Sub-forum 1: Chemical Drug Forum Qiu Jing, Ph.
D.
, senior engineer of Jiangsu Medical Device Inspection Institute, "Analysis Technology and Quality Control of Injection Packaging Materials" Liu Junfeng Director of Changzhou Import and Export Industry and Consumer Product Safety Testing Center "Intelligent Solutions for Laboratory Chemical Management" Yang Qian Director of Technology Department of Sanyao Fine Chemicals Sales (Beijing) Co.
, Ltd.
"HPLC method development - from molecular structure to establishment of analytical methods" Lai Jianmei, head of cleaning verification technology of Shi Qile Company "Controlling OOS in laboratory utensil cleaning from the source" Gu Xiao "Research on Organic Impurities and Elemental Impurities of Chemicals" by Zhejiang Food and Drug Inspection and Research Institute Technical Requirements and Compatibility Research Strategies for Syringes" Wu Guohua, Pharmaceutical Industry Manager, Marketing Department of Shimadzu Enterprise Management (China) Co.
, Ltd.
"Research on Analysis and Detection of Genetic Toxic Impurities in Chemical Drugs" Leng Xiangyang, SCIEX Application Expert "SCIEXGenotoxic Impurities and Pharmaceutical Packaging Materials LC/MS Frontier Technology Scheme” Jia Fei Deputy Director of Youth Sub-Committee of Pharmaceutical Analysis Professional Committee of Zhejiang Pharmaceutical Association, Deputy General Manager of Hangzhou Baicheng Pharmaceutical Technology Co.
, Ltd.
“Change Technology of Listed Drugs” Application of research requirements in the process of drug research and development" Chen Jiandong, quality director and researcher of Zhejiang Jingxin Pharmaceutical Co.
, Ltd.
"Analysis and response to technical difficulties in the development of analytical methods for trace impurities in drugs" Xie Baohui Huazhi (Fujian) Electronic Technology Co.
, Ltd.
R&D director " Image Analysis Technology Accurately Identifying Melting Points to Help Drug Research and Development" Yang Weifeng Zhejiang Institute of Food and Drug Inspection "Related Substances Research and Residual Solvent Determination" Sub-forum 2: Chinese Medicine Forum Lu Jing, former deputy director of the National Institute for the Control of Chinese Medicines, China National Institute for Food and Drug Control "Research on Chinese Medicine Reference Substances" Tang Ji Heliyang Enterprise Co.
, Ltd.
Product Manager "A New Digital Era of Thin Layer Chromatography - HPTLC PRO and Digital Traditional Chinese Medicine" Guo Zengxi, Zhejiang Institute of Food and Drug Inspection "Identification of multi-source medicinal materials Dendrobium, Chinese yam, etc.
" Zhu Ming, consultant expert of Zhejiang Institute of Food and Drug Inspection, "Interpretation and Precautions of Chinese Pharmacopoeia 2020 Edition Standard Changes in Traditional Chinese Medicine" Hu Haobin, Deputy Director of Chinese Medicine Office of Jiangsu Province Institute of Food and Drug Inspection, "Standard Analysis of Chinese Herbal Medicines and Chinese Herbal Pieces" Sub-forum three: Microbiology Forum Zheng Xiaoling, Deputy Director of the Institute of Microbiology, Zhejiang Institute of Food and Drug Inspection, "Microbiological Quality Control Research and Case Analysis", "Hot Issues and Solutions for Microbiological Research in the Pharmaceutical Industry" Li Yanchang, Senior Engineer of Guangdong Huankai Microbiological Technology Co.
, Ltd.
"Pharmaceutical Industry Training Analysis and Discussion of Key Points in Quality Control of Basic Quality, Zhang Yanan, Director of the Institute of Microbiology, Zhejiang Provincial Center for Disease Control and Prevention, Laboratory Biosafety Management and Emergency Response, Molecular Detection Technology of Microorganisms, Zhang Yajie, Director of the Microbiology Office of Liaoning Drug Inspection and Testing Institute Microbiology Laboratory Management and Frequently Asked Questions" In order to let the participants have a more intuitive understanding of the solutions of various manufacturers in the pharmaceutical industry and facilitate the communication between enterprises and manufacturers, a manufacturer booth was set up outside the venue to facilitate the guests and manufacturers.
More communication and learning opportunitiesand Digital Chinese Medicine” Guo Zengxi, Zhejiang Provincial Institute of Food and Drug Inspection, “Identification of multi-source medicinal materials Dendrobium, Chinese yam, etc.
” Zhu Ming, consultant expert of Zhejiang Provincial Institute of Food and Drug Inspection, “Interpretation and Precautions for the Change of Chinese Pharmacopoeia 2020 Edition Chinese Medicine Standards” Hu Haobin, Jiangsu Province "Standard Analysis of Chinese Medicinal Materials and Chinese Herbal Pieces" Sub-forum 3: Microbial Forum Zheng Xiaoling, Deputy Director of the Institute of Microbiology, Zhejiang Food and Drug Inspection and Research Institute "Microbiological Quality Control Research and Case Analysis" "Pharmaceutical Industry Microbiological-related research hot issues and solutions" Li Yanchang, senior engineer of Guangdong Huankai Microbial Technology Co.
, Ltd.
"Analysis and discussion of key points in the quality control of culture medium in the pharmaceutical industry" Zhang Yanchang, director of the Institute of Microbiology, Zhejiang Provincial Center for Disease Control and Prevention, "Laboratory Biosafety Management" and Emergency Response" "Molecular Detection Technology of Microorganisms" Zhang Yajie, Director of the Microbiology Department of Liaoning Drug Inspection and Testing Institute, "Pharmaceutical Microbiology Laboratory Management and Frequently Asked Questions" In order to let the participants have a more intuitive understanding of the solutions of various manufacturers in the pharmaceutical industry, To facilitate communication between enterprises and manufacturers, a manufacturer booth was set up outside the venue to facilitate more communication and learning opportunities for guests and manufacturers.
and Digital Chinese Medicine” Guo Zengxi, Zhejiang Provincial Institute of Food and Drug Inspection, “Identification of multi-source medicinal materials Dendrobium, Chinese yam, etc.
” Zhu Ming, consultant expert of Zhejiang Provincial Institute of Food and Drug Inspection, “Interpretation and Precautions for the Change of Chinese Pharmacopoeia 2020 Edition Chinese Medicine Standards” Hu Haobin, Jiangsu Province "Standard Analysis of Chinese Medicinal Materials and Chinese Herbal Pieces" Sub-forum 3: Microbial Forum Zheng Xiaoling, Deputy Director of the Institute of Microbiology, Zhejiang Food and Drug Inspection and Research Institute "Microbiological Quality Control Research and Case Analysis" "Pharmaceutical Industry Microbiological-related research hot issues and solutions" Li Yanchang, senior engineer of Guangdong Huankai Microbial Technology Co.
, Ltd.
"Analysis and discussion of key points in the quality control of culture medium in the pharmaceutical industry" Zhang Yanchang, director of the Institute of Microbiology, Zhejiang Provincial Center for Disease Control and Prevention, "Laboratory Biosafety Management" and Emergency Response" "Molecular Detection Technology of Microorganisms" Zhang Yajie, Director of the Microbiology Department of Liaoning Drug Inspection and Testing Institute, "Pharmaceutical Microbiology Laboratory Management and Frequently Asked Questions" In order to let the participants have a more intuitive understanding of the solutions of various manufacturers in the pharmaceutical industry, To facilitate communication between enterprises and manufacturers, a manufacturer booth was set up outside the venue to facilitate more communication and learning opportunities for guests and manufacturers.
.
Exhibitor Communication Thank you all for your support and participation! In a warm atmosphere, this forum came to a successful conclusion
.
This grand event has received extensive participation from all walks of life in the pharmaceutical industry, which has inspired the confidence of pharmaceutical companies in drug testing, and has positive and far-reaching significance
.
Finally, Hangzhou Qiyi would like to express its heartfelt thanks to all the leaders, experts, exhibitors and guests who came to the conference! Hangzhou Qiyi Technology Co.
, Ltd.
is a platform operator specializing in laboratory procurement.
The company owns a one-stop procurement platform called "experimental.
com", which is a vertical vertical procurement platform for domestic scientific research experiments, focusing on pharmaceutical companies, scientific research institutes, Universities, medical institutions and other industries provide one-stop procurement services for laboratory buyers, allowing buyers to easily purchase high-quality and low-cost supplies
.
Experiment.
com focuses on small but refined, refined and beautiful, beautiful and specialized butler->
.
, Ltd.
Hangzhou kicked off, and many experts and teachers from the pharmaceutical industry gathered together
.
During the two days, more than 300 industry colleagues from pharmaceutical companies QC, drug regulatory agencies, drug inspection institutes, and pharmaceutical company managers participated in the conference! During the two days, big names gathered, and everyone benefited a lot.
The content of the report was splendid and presented an academic feast.
Speech by the Secretary of the Professional Committee of Pharmaceutical Analysis of Zhejiang Pharmaceutical Association Li Yang, Deputy Director of the Professional Committee of Pharmaceutical Analysis of Zhejiang Pharmaceutical Association, Vice President Li of Zhejiang Provincial Institute of Food and Drug Inspection delivered an enthusiastic opening speech, which opened the At the prelude of the conference, President Li said: With the continuous improvement of the quality of life, people are paying more and more attention to health, and the demand for food and drug safety has been incorporated into an important indicator for measuring a well-off society
.
Investing in health has become a consumption fad and a hot pursuit
.
Therefore, drug quality control is a crucial step
.
This year is the year of the implementation of the 2020 edition of the "Chinese Pharmacopoeia".
The "Chinese Pharmacopoeia" is the standard for drug safety, and in a strict sense, it is also a firewall for drug safety
.
The advent of the "Chinese Pharmacopoeia" has greatly improved the standards of medicines.
It is a medicine code formulated by the state to ensure the controllable quality of medicines and the safety and effectiveness of the people's medicines.
It must be strictly followed in the development, production, operation, use and management of medicines.
The legal basis is the core of the national drug standard system and an important part of international exchanges and cooperation
.
It has promoted the overall improvement of China's drug testing and testing skills, and also strengthened drug testing and control
.
Dean Li spoke highly of and affirmed the preparation and organization of this conference
.
Finally, I wish this forum a complete success! In just two days, speakers from the Pharmacopoeia Committee, regulatory authorities, and enterprises shared nearly 25 keynote reports on the interpretation of the 2020 edition of the Chinese Pharmacopoeia, cutting-edge technologies and challenges in modern pharmaceutical analysis, injections, and pharmaceutical raw materials.
, Chemical organic impurities and elemental impurities research, related substance research and residual solvent determination, Chinese medicine standard research, Chinese herbal medicine and Chinese medicine decoction pieces, microbial quality control research and case analysis, laboratory biosafety management, drug microbiology laboratory management and common problems and other issues to discuss, analyze and preach laboratory management experience, drug analysis and detection and microbial control and other problems
.
General Assembly Yu Lushan Deputy Director of the Pharmaceutical Analysis Professional Committee of Zhejiang Pharmaceutical Association, Deputy Director of the Institute of Drug Metabolism and Drug Analysis, School of Pharmacy, Zhejiang University "Frontier Technologies and Challenges in Modern Pharmaceutical Analysis" Wang Jian Member of the State Pharmacopoeia Committee, Zhejiang Provincial Food and Drug Inspection Research Institute "two-dimensional liquid chromatography-mass spectrometry technology and its application in the analysis of high-risk impurities in antibiotics" Li Yu Zhejiang Institute of Food and Drug Inspection "Compatibility Research and Case Analysis of Polymorphic Drug Raw Materials and Excipients" Sub-forum 1: Chemical Drug Forum Qiu Jing, Ph.
D.
, senior engineer of Jiangsu Medical Device Inspection Institute, "Analysis Technology and Quality Control of Injection Packaging Materials" Liu Junfeng Director of Changzhou Import and Export Industry and Consumer Product Safety Testing Center "Intelligent Solutions for Laboratory Chemical Management" Yang Qian Director of Technology Department of Sanyao Fine Chemicals Sales (Beijing) Co.
, Ltd.
"HPLC method development - from molecular structure to establishment of analytical methods" Lai Jianmei, head of cleaning verification technology of Shi Qile Company "Controlling OOS in laboratory utensil cleaning from the source" Gu Xiao "Research on Organic Impurities and Elemental Impurities of Chemicals" by Zhejiang Food and Drug Inspection and Research Institute Technical Requirements and Compatibility Research Strategies for Syringes" Wu Guohua, Pharmaceutical Industry Manager, Marketing Department of Shimadzu Enterprise Management (China) Co.
, Ltd.
"Research on Analysis and Detection of Genetic Toxic Impurities in Chemical Drugs" Leng Xiangyang, SCIEX Application Expert "SCIEXGenotoxic Impurities and Pharmaceutical Packaging Materials LC/MS Frontier Technology Scheme” Jia Fei Deputy Director of Youth Sub-Committee of Pharmaceutical Analysis Professional Committee of Zhejiang Pharmaceutical Association, Deputy General Manager of Hangzhou Baicheng Pharmaceutical Technology Co.
, Ltd.
“Change Technology of Listed Drugs” Application of research requirements in the process of drug research and development" Chen Jiandong, quality director and researcher of Zhejiang Jingxin Pharmaceutical Co.
, Ltd.
"Analysis and response to technical difficulties in the development of analytical methods for trace impurities in drugs" Xie Baohui Huazhi (Fujian) Electronic Technology Co.
, Ltd.
R&D director " Image Analysis Technology Accurately Identifying Melting Points to Help Drug Research and Development" Yang Weifeng Zhejiang Institute of Food and Drug Inspection "Related Substances Research and Residual Solvent Determination" Sub-forum 2: Chinese Medicine Forum Lu Jing, former deputy director of the National Institute for the Control of Chinese Medicines, China National Institute for Food and Drug Control "Research on Chinese Medicine Reference Substances" Tang Ji Heliyang Enterprise Co.
, Ltd.
Product Manager "A New Digital Era of Thin Layer Chromatography - HPTLC PRO and Digital Traditional Chinese Medicine" Guo Zengxi, Zhejiang Institute of Food and Drug Inspection "Identification of multi-source medicinal materials Dendrobium, Chinese yam, etc.
" Zhu Ming, consultant expert of Zhejiang Institute of Food and Drug Inspection, "Interpretation and Precautions of Chinese Pharmacopoeia 2020 Edition Standard Changes in Traditional Chinese Medicine" Hu Haobin, Deputy Director of Chinese Medicine Office of Jiangsu Province Institute of Food and Drug Inspection, "Standard Analysis of Chinese Herbal Medicines and Chinese Herbal Pieces" Sub-forum three: Microbiology Forum Zheng Xiaoling, Deputy Director of the Institute of Microbiology, Zhejiang Institute of Food and Drug Inspection, "Microbiological Quality Control Research and Case Analysis", "Hot Issues and Solutions for Microbiological Research in the Pharmaceutical Industry" Li Yanchang, Senior Engineer of Guangdong Huankai Microbiological Technology Co.
, Ltd.
"Pharmaceutical Industry Training Analysis and Discussion of Key Points in Quality Control of Basic Quality, Zhang Yanan, Director of the Institute of Microbiology, Zhejiang Provincial Center for Disease Control and Prevention, Laboratory Biosafety Management and Emergency Response, Molecular Detection Technology of Microorganisms, Zhang Yajie, Director of the Microbiology Office of Liaoning Drug Inspection and Testing Institute Microbiology Laboratory Management and Frequently Asked Questions" In order to let the participants have a more intuitive understanding of the solutions of various manufacturers in the pharmaceutical industry and facilitate the communication between enterprises and manufacturers, a manufacturer booth was set up outside the venue to facilitate the guests and manufacturers.
More communication and learning opportunitiesand Digital Chinese Medicine” Guo Zengxi, Zhejiang Provincial Institute of Food and Drug Inspection, “Identification of multi-source medicinal materials Dendrobium, Chinese yam, etc.
” Zhu Ming, consultant expert of Zhejiang Provincial Institute of Food and Drug Inspection, “Interpretation and Precautions for the Change of Chinese Pharmacopoeia 2020 Edition Chinese Medicine Standards” Hu Haobin, Jiangsu Province "Standard Analysis of Chinese Medicinal Materials and Chinese Herbal Pieces" Sub-forum 3: Microbial Forum Zheng Xiaoling, Deputy Director of the Institute of Microbiology, Zhejiang Food and Drug Inspection and Research Institute "Microbiological Quality Control Research and Case Analysis" "Pharmaceutical Industry Microbiological-related research hot issues and solutions" Li Yanchang, senior engineer of Guangdong Huankai Microbial Technology Co.
, Ltd.
"Analysis and discussion of key points in the quality control of culture medium in the pharmaceutical industry" Zhang Yanchang, director of the Institute of Microbiology, Zhejiang Provincial Center for Disease Control and Prevention, "Laboratory Biosafety Management" and Emergency Response" "Molecular Detection Technology of Microorganisms" Zhang Yajie, Director of the Microbiology Department of Liaoning Drug Inspection and Testing Institute, "Pharmaceutical Microbiology Laboratory Management and Frequently Asked Questions" In order to let the participants have a more intuitive understanding of the solutions of various manufacturers in the pharmaceutical industry, To facilitate communication between enterprises and manufacturers, a manufacturer booth was set up outside the venue to facilitate more communication and learning opportunities for guests and manufacturers.
and Digital Chinese Medicine” Guo Zengxi, Zhejiang Provincial Institute of Food and Drug Inspection, “Identification of multi-source medicinal materials Dendrobium, Chinese yam, etc.
” Zhu Ming, consultant expert of Zhejiang Provincial Institute of Food and Drug Inspection, “Interpretation and Precautions for the Change of Chinese Pharmacopoeia 2020 Edition Chinese Medicine Standards” Hu Haobin, Jiangsu Province "Standard Analysis of Chinese Medicinal Materials and Chinese Herbal Pieces" Sub-forum 3: Microbial Forum Zheng Xiaoling, Deputy Director of the Institute of Microbiology, Zhejiang Food and Drug Inspection and Research Institute "Microbiological Quality Control Research and Case Analysis" "Pharmaceutical Industry Microbiological-related research hot issues and solutions" Li Yanchang, senior engineer of Guangdong Huankai Microbial Technology Co.
, Ltd.
"Analysis and discussion of key points in the quality control of culture medium in the pharmaceutical industry" Zhang Yanchang, director of the Institute of Microbiology, Zhejiang Provincial Center for Disease Control and Prevention, "Laboratory Biosafety Management" and Emergency Response" "Molecular Detection Technology of Microorganisms" Zhang Yajie, Director of the Microbiology Department of Liaoning Drug Inspection and Testing Institute, "Pharmaceutical Microbiology Laboratory Management and Frequently Asked Questions" In order to let the participants have a more intuitive understanding of the solutions of various manufacturers in the pharmaceutical industry, To facilitate communication between enterprises and manufacturers, a manufacturer booth was set up outside the venue to facilitate more communication and learning opportunities for guests and manufacturers.
.
Exhibitor Communication Thank you all for your support and participation! In a warm atmosphere, this forum came to a successful conclusion
.
This grand event has received extensive participation from all walks of life in the pharmaceutical industry, which has inspired the confidence of pharmaceutical companies in drug testing, and has positive and far-reaching significance
.
Finally, Hangzhou Qiyi would like to express its heartfelt thanks to all the leaders, experts, exhibitors and guests who came to the conference! Hangzhou Qiyi Technology Co.
, Ltd.
is a platform operator specializing in laboratory procurement.
The company owns a one-stop procurement platform called "experimental.
com", which is a vertical vertical procurement platform for domestic scientific research experiments, focusing on pharmaceutical companies, scientific research institutes, Universities, medical institutions and other industries provide one-stop procurement services for laboratory buyers, allowing buyers to easily purchase high-quality and low-cost supplies
.
Experiment.
com focuses on small but refined, refined and beautiful, beautiful and specialized butler->
.
